GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Cyclically Adjusted PS Ratio

Kaken Pharmaceutical Co (TSE:4521) Cyclically Adjusted PS Ratio : 1.46 (As of May. 07, 2024)


View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-05-07), Kaken Pharmaceutical Co's current share price is 円3468.00. Kaken Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円2,380.89. Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 1.46.

The historical rank and industry rank for Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4521' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.34   Med: 2.03   Max: 2.99
Current: 1.46

During the past years, Kaken Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 2.99. The lowest was 1.34. And the median was 2.03.

TSE:4521's Cyclically Adjusted PS Ratio is ranked better than
62.82% of 745 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs TSE:4521: 1.46

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Kaken Pharmaceutical Co's adjusted revenue per share data for the three months ended in Dec. 2023 was 円488.883. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円2,380.89 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kaken Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Kaken Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.25 2.19 1.90 1.69 1.57

Kaken Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.65 1.57 1.52 1.47 1.41

Competitive Comparison of Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Kaken Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3468.00/2380.89
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaken Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Kaken Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=488.883/106.8000*106.8000
=488.883

Current CPI (Dec. 2023) = 106.8000.

Kaken Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 518.966 95.700 579.160
201406 508.927 98.000 554.627
201409 538.900 98.500 584.310
201412 637.246 97.900 695.177
201503 548.798 97.900 598.689
201506 667.061 98.400 724.005
201509 659.956 98.500 715.567
201512 735.221 98.100 800.424
201603 574.482 97.900 626.708
201606 633.664 98.100 689.861
201609 626.745 98.000 683.024
201612 646.911 98.400 702.135
201703 563.369 98.100 613.331
201706 611.472 98.500 662.997
201709 615.996 98.800 665.874
201712 670.412 99.400 720.322
201803 534.251 99.200 575.182
201806 599.062 99.200 644.958
201809 588.002 99.900 628.615
201812 631.024 99.700 675.962
201903 543.406 99.700 582.104
201906 562.935 99.800 602.419
201909 584.793 100.100 623.935
201912 641.922 100.500 682.162
202003 489.607 100.300 521.336
202006 464.322 99.900 496.392
202009 483.383 99.900 516.770
202012 528.574 99.300 568.497
202103 466.968 99.900 499.221
202106 481.701 99.500 517.042
202109 503.977 100.100 537.710
202112 506.062 100.100 539.934
202203 484.584 101.100 511.905
202206 481.300 101.800 504.939
202209 496.216 103.100 514.024
202212 500.467 104.100 513.447
202303 464.603 104.400 475.284
202306 484.362 105.200 491.729
202309 477.529 106.200 480.227
202312 488.883 106.800 488.883

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kaken Pharmaceutical Co  (TSE:4521) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Kaken Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kaken Pharmaceutical Co (TSE:4521) Business Description

Traded in Other Exchanges
Address
28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650
Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines